跳至主要内容
临床试验/EUCTR2011-001408-37-IT
EUCTR2011-001408-37-IT进行中(未招募)不适用

Effects of Liraglutide on left ventricular (LV) morphology, function and energy metabolism in patients with type 2 diabetes and heart failure : an in vivo cardiac Magnetic Resonance Imaging and 31P Spectroscopy study.

FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR0 个研究点开始时间: 2012年4月10日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • - Age between 40-70 years - men with type 2 diabetes for at least 1 year - HbA1c> 7% but less than 10% for at least the last 6 months during treatment with metformin 2 g / day - Ejection Fraction <50% but not more than 25%
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • - Body mass index> 32 kg/m2 - autonomic neuropathy - Creatinine> 1.5 mg / dl - Any disease / condition that might interfere with the study - Unstable Angina - Arrhythmia - Patients on metabolic treatment (trimetazidine, acipimox, perhexeline, thyroid hormones) - Patients unable to attend the study or to undergo testing protocol (contraindications to MRI such as pacemakers, metal objects and non-removable) - Claustrophobia - Anterior myocardial infarction

研究者

发起方
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR

相似试验